New research shows that postmenopausal women who reached menopause at an earlier age or who never gave birth at all are at a higher risk for developing heart failure.

Lancaster General Hospital has lowest Medicare heart failure readmission rate in the U.S., according to government statistics. How this facility managed to become a leader in the field has to do with patient engagement.

Being unemployed could have deadly consequences for patients suffering from heart failure, a new study finds.

A new scientific statement published by the American Heart Association (AHA) suggests that innovative biomarker tests for heart failure could help physicians better diagnose and treat the condition.

American Regent announced on April 24 that the first patients had enrolled in a phase 3 trial evaluating an investigational heart failure medication.

The FDA determined that Medtronic’s voluntary recall of its HVAD system controllers and DC adapters was a class I recall, according to a Medtronic news release on April 18.

MARLBOROUGH, Mass., April 18, 2017 /PRNewswire/ -- Boston Scientific (NYSE:  BSX) has initiated a worldwide study that will evaluate the survival benefit of patients treated with the EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System who are aged 65 and older with a history of prior heart attack, diabetes and moderately reduced left ventricular ejection fraction.

New research has found that being in a city where a major marathon is being hosted can increase the risk of heart attack and cardiac arrest, reports Reuters.